|
US7189834B2
(en)
*
|
1993-05-11 |
2007-03-13 |
Marshall William E |
Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
|
|
US20030109469A1
(en)
*
|
1993-08-26 |
2003-06-12 |
Carson Dennis A. |
Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
|
|
US6727230B1
(en)
*
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US7935675B1
(en)
*
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
US5981501A
(en)
*
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
|
US7422902B1
(en)
*
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
CA2289702C
(en)
*
|
1997-05-14 |
2008-02-19 |
Inex Pharmaceuticals Corp. |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
|
AU760795B2
(en)
*
|
1998-05-14 |
2003-05-22 |
Coley Pharmaceutical Gmbh |
Methods for regulating hematopoiesis using CpG-oligonucleotides
|
|
PT1733735T
(pt)
*
|
1998-05-22 |
2017-06-16 |
Ottawa Hospital Res Inst |
Métodos e produtos para induzir imunidade mucosal
|
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
EP2204186B1
(en)
|
1999-02-17 |
2016-04-06 |
CSL Limited |
Immunogenic complexes and methods relating thereto
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US20050002958A1
(en)
*
|
1999-06-29 |
2005-01-06 |
Smithkline Beecham Biologicals Sa |
Vaccines
|
|
AU774380B2
(en)
|
1999-08-19 |
2004-06-24 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
|
CZ301488B6
(cs)
*
|
1999-09-25 |
2010-03-24 |
University Of Iowa Research Foundation |
Použití imunostimulacních nukleových kyselin
|
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
DE60043759D1
(de)
*
|
1999-12-13 |
2010-03-11 |
Bioniche Life Sciences Inc |
Therapeutisch nützliche synthetische Oligonukleotide
|
|
DE60131430T2
(de)
*
|
2000-01-14 |
2008-10-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
|
US6552006B2
(en)
|
2000-01-31 |
2003-04-22 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
CA2399550A1
(en)
|
2000-02-23 |
2001-08-30 |
The Regents Of The University Of California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
|
KR100863632B1
(ko)
|
2000-03-31 |
2008-10-15 |
퍼듀 리서치 파운데이션 |
리간드-면역원 접합체를 사용한 치료 방법
|
|
AU2001281812B2
(en)
|
2000-06-08 |
2005-04-07 |
Valneva Austria Gmbh |
Immunostimulatory oligodeoxynucleotides
|
|
EP1315672A4
(en)
|
2000-06-22 |
2006-04-26 |
Rxkinetix Inc |
ADMINISTRATIVE COMPOSITION COMPOSITION AND METHOD FOR THE ADMINISTRATION OF ANTIGENES AND OTHER ACTIVE SUBSTANCES
|
|
CA2410371C
(en)
*
|
2000-06-22 |
2015-11-17 |
University Of Iowa Research Foundation |
Methods for enhancing antibody-induced cell lysis and treating cancer
|
|
KR100917101B1
(ko)
*
|
2000-08-04 |
2009-09-15 |
도요 보세키 가부시키가이샤 |
플렉시블 금속적층체 및 그 제조방법
|
|
AU2001291096A1
(en)
|
2000-09-15 |
2002-03-26 |
Coley Pharmaceutical Gmbh |
Process for high throughput screening of CpG-based immuno-agonist/antagonist
|
|
WO2002069369A2
(en)
*
|
2000-12-08 |
2002-09-06 |
Coley Pharmaceutical Gmbh |
Cpg-like nucleic acids and methods of use thereof
|
|
KR100881923B1
(ko)
|
2000-12-27 |
2009-02-04 |
다이나박스 테크놀로지 코퍼레이션 |
면역자극 폴리뉴클레오티드 및 그것의 사용 방법
|
|
EP2423335B1
(en)
|
2001-06-21 |
2014-05-14 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same
|
|
US7785610B2
(en)
*
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
|
US20040132677A1
(en)
*
|
2001-06-21 |
2004-07-08 |
Fearon Karen L. |
Chimeric immunomodulatory compounds and methods of using the same-IV
|
|
EP1572124A4
(en)
*
|
2001-06-29 |
2007-11-28 |
Novartis Vaccines & Diagnostic |
HCV E1E2 VACCINE COMPOSITIONS
|
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
|
AU2002326561B2
(en)
|
2001-08-07 |
2008-04-03 |
Dynavax Technologies Corporation |
Immunomodulatory compositions, formulations, and methods for use thereof
|
|
WO2003020884A2
(en)
*
|
2001-08-14 |
2003-03-13 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Method for rapid generation of mature dendritic cells
|
|
SG177000A1
(en)
*
|
2001-08-17 |
2012-01-30 |
Coley Pharm Gmbh |
Combination motif immune stimulatory oligonucleotides with improved activity
|
|
AU2008200016B2
(en)
*
|
2001-08-17 |
2012-04-19 |
Coley Pharmaceutical Gmbh |
Combination motif immune stimulatory oligonucleotides with improved activity
|
|
JP2005501917A
(ja)
*
|
2001-09-07 |
2005-01-20 |
ザ トラスティーズ オブ ボストン ユニバーシティ |
免疫複合体関連疾患を処置するための方法および組成物
|
|
JP4516748B2
(ja)
*
|
2001-09-14 |
2010-08-04 |
サイトス バイオテクノロジー アーゲー |
ウィルス様粒子中への免疫賦活物質のパッケージ化：調製法および使用法
|
|
KR20040053136A
(ko)
*
|
2001-09-28 |
2004-06-23 |
펄듀 리서치 파운데이션 |
리간드-면역원 공액체를 이용한 치료 방법
|
|
WO2003030656A2
(en)
|
2001-10-06 |
2003-04-17 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
|
CA2462203A1
(en)
*
|
2001-10-12 |
2003-11-20 |
University Of Iowa Research Foundation |
Methods and products for enhancing immune responses using imidazoquinoline compounds
|
|
US7276489B2
(en)
*
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
EP1441763A2
(en)
*
|
2001-11-07 |
2004-08-04 |
Inex Pharmaceuticals Corp. |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
|
WO2003054161A2
(en)
*
|
2001-12-20 |
2003-07-03 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
|
WO2003055514A1
(en)
|
2001-12-21 |
2003-07-10 |
Antigenics Inc. |
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
|
|
US8088388B2
(en)
*
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
NZ573064A
(en)
|
2002-04-04 |
2011-02-25 |
Coley Pharm Gmbh |
Immunostimulatory G,U-containing oligoribonucleotides
|
|
AU2003219383B2
(en)
*
|
2002-04-22 |
2010-08-26 |
Bioniche Life Sciences Inc. |
Oligonucleotide compositions and their use for the modulation of immune responses
|
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
|
KR100456681B1
(ko)
*
|
2002-05-22 |
2004-11-10 |
주식회사 대웅 |
박테리아의 염색체 ｄｎａ 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
|
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
|
BR0311995A
(pt)
*
|
2002-06-20 |
2005-04-05 |
Cytos Biotechnology Ag |
Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
|
|
EP1539215A2
(en)
*
|
2002-06-25 |
2005-06-15 |
City of Hope |
Adjuvant-free peptide vaccine
|
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7576066B2
(en)
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
EP1551221A4
(en)
*
|
2002-07-03 |
2007-08-01 |
Coley Pharm Group Inc |
NUCLEIC ACID COMPOSITIONS FOR STIMULATING IMMUNE RESPONSES
|
|
US20040053880A1
(en)
*
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
AR040996A1
(es)
*
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
|
SG166673A1
(en)
*
|
2002-08-19 |
2010-12-29 |
Coley Pharm Group Inc |
Immunostimulatory nucleic acids
|
|
CA2498777C
(en)
*
|
2002-09-13 |
2015-01-13 |
Replicor, Inc. |
Non-sequence complementary antiviral oligonucleotides
|
|
US8263091B2
(en)
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
|
ATE544466T1
(de)
|
2002-10-29 |
2012-02-15 |
Coley Pharm Group Inc |
Verwendung von cpg oligonukleotide zur behandlung von hepatitis c virus infektion
|
|
JP4976653B2
(ja)
|
2002-11-01 |
2012-07-18 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシス |
免疫刺激性ＣｐＧオリゴヌクレオチドを用いてバイオテロ病原体による感染症を予防する方法
|
|
AU2003300919A1
(en)
|
2002-12-11 |
2004-06-30 |
Coley Pharmaceutical Gmbh |
5' cpg nucleic acids and methods of use
|
|
US7317142B2
(en)
|
2002-12-13 |
2008-01-08 |
Prodi Gene, Inc. |
Immunization of fish with plant-expressed recombinant proteins
|
|
WO2004058179A2
(en)
|
2002-12-23 |
2004-07-15 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
US8158768B2
(en)
*
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
WO2004058159A2
(en)
|
2002-12-23 |
2004-07-15 |
Dynavax Technologies Corporation |
Branched immunomodulatory compounds and methods of using the same
|
|
ES2385933T3
(es)
|
2003-02-20 |
2012-08-03 |
University Of Connecticut Health Center |
Métodos para la producción de complejos de moléculas antígenas de alfa (2) macroglobulina.
|
|
US7537767B2
(en)
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
|
ZA200507562B
(en)
*
|
2003-03-26 |
2006-11-29 |
Cytos Biotechnology Ag |
HIV-peptide-carrier-conjugates
|
|
EP1608403A2
(en)
*
|
2003-04-02 |
2005-12-28 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
|
KR101066788B1
(ko)
*
|
2003-04-09 |
2011-09-21 |
노바르티스 아게 |
공기 입구 차폐 부재를 갖춘 에어로졸화 장치
|
|
CA2527756C
(en)
*
|
2003-05-15 |
2014-05-06 |
Japan Science And Technology Agency |
Immunostimulating agents
|
|
US7410975B2
(en)
|
2003-06-20 |
2008-08-12 |
Coley Pharmaceutical Group, Inc. |
Small molecule toll-like receptor (TLR) antagonists
|
|
DE602004031017D1
(de)
|
2003-07-10 |
2011-02-24 |
Cytos Biotechnology Ag |
Zusammensetzung verpackte virusartige teilchen umfassend zur verstärkung einer immunantwort
|
|
CN1867355A
(zh)
*
|
2003-08-11 |
2006-11-22 |
财团法人阪大微生物病研究会 |
包含诱导粘膜免疫的佐剂的新型疫苗
|
|
GB2388581A
(en)
|
2003-08-22 |
2003-11-19 |
Danisco |
Coated aqueous beads
|
|
US20070042184A1
(en)
|
2003-08-22 |
2007-02-22 |
Danisco A/S |
Microcapsules
|
|
JP2007505147A
(ja)
|
2003-09-12 |
2007-03-08 |
アンティジェニクス インコーポレーテッド |
単純ヘルペスウイルス感染の治療および予防用ワクチン
|
|
CA2536139A1
(en)
|
2003-09-25 |
2005-04-07 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid-lipophilic conjugates
|
|
JP2007509040A
(ja)
*
|
2003-10-11 |
2007-04-12 |
イネックス ファーマシューティカルズ コーポレイション |
先天性免疫及び抗体依存性細胞傷害を強化するための方法及び組成物
|
|
US8188254B2
(en)
|
2003-10-30 |
2012-05-29 |
Coley Pharmaceutical Gmbh |
C-class oligonucleotide analogs with enhanced immunostimulatory potency
|
|
US20050239733A1
(en)
*
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
|
US20050100983A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Coley Pharmaceutical Gmbh |
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
|
|
AU2004304770B2
(en)
*
|
2003-12-08 |
2010-05-06 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties by small oligonucleotide-based compounds
|
|
DE10361502A1
(de)
*
|
2003-12-23 |
2005-07-28 |
Phenion Gmbh & Co. Kg |
Kosmetische oder pharmazeutische Zubereitungen enthaltend Superstruktur-bildende Nukleinsäure-Sequenzen
|
|
KR100558851B1
(ko)
*
|
2004-01-08 |
2006-03-10 |
학교법인연세대학교 |
면역조절능력이 증가된 ＣｐＧ 올리고데옥시뉴클레오티드변형체
|
|
WO2005072290A2
(en)
*
|
2004-01-23 |
2005-08-11 |
Joslin Diabetes Center |
Methods of treating, reducing, or preventing autoimmune conditions
|
|
CA2555390C
(en)
*
|
2004-02-19 |
2014-08-05 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral rna oligonucleotides
|
|
US20060019916A1
(en)
*
|
2004-04-02 |
2006-01-26 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing IL-10 responses
|
|
US20080113929A1
(en)
*
|
2004-06-08 |
2008-05-15 |
Coley Pharmaceutical Gmbh |
Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist
|
|
US7674456B2
(en)
*
|
2004-06-14 |
2010-03-09 |
Charles Wiseman |
Breast cancer cell lines and uses thereof
|
|
JP2008506789A
(ja)
*
|
2004-07-18 |
2008-03-06 |
シーエスエル、リミテッド |
インターフェロン−ガンマ応答強化を誘発するための免疫刺激複合体及びオリゴヌクレオチド処方物
|
|
US8859275B2
(en)
|
2004-08-03 |
2014-10-14 |
Geneart Ag |
Method for modulating gene expression by modifying the CpG content
|
|
KR101268877B1
(ko)
|
2004-09-01 |
2013-05-31 |
다이나박스 테크놀로지 코퍼레이션 |
선천성 면역반응 및 자가면역의 억제를 위한 방법 및조성물
|
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
|
EP1657307A1
(en)
*
|
2004-11-16 |
2006-05-17 |
Immunotech S.A. |
Oligonucleotides that induce the secretion of GM-CSF
|
|
AU2006216493A1
(en)
*
|
2005-02-24 |
2006-08-31 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligonucleotides
|
|
JP5403457B2
(ja)
*
|
2005-02-28 |
2014-01-29 |
株式会社明治 |
Ａｔオリゴヌクレオチドを有効成分とする免疫応答増強性薬剤及び食品組成物
|
|
JP2008531722A
(ja)
|
2005-03-04 |
2008-08-14 |
ダイナバックス テクノロジーズ コーポレイション |
構造的に安定なコンジュゲート分子を含む組成物
|
|
NZ561040A
(en)
|
2005-03-18 |
2009-04-30 |
Cytos Biotechnology Ag |
Cat allergen fusion proteins and use thereof
|
|
EP1874325A2
(en)
*
|
2005-04-08 |
2008-01-09 |
Coley Pharmaceutical Group, Inc. |
Methods for treating infectious disease exacerbated asthma
|
|
JP2008535862A
(ja)
|
2005-04-08 |
2008-09-04 |
キメリクス，インコーポレイテッド |
ポックスウイルス感染の治療のための化合物、組成物および方法
|
|
KR101364003B1
(ko)
|
2005-04-28 |
2014-02-21 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
활성화된 제ｖｉｉ 인자 폴리펩타이드를 포함하는 밀폐용기와 이의 제조방법 및, 키트와 키트의 사용방법
|
|
DE102005022290A1
(de)
*
|
2005-05-13 |
2006-11-16 |
Universitätsklinikum Schleswig-Holstein |
Hexanukleotid-Wirkstoffe
|
|
CN1865275B
(zh)
|
2005-05-17 |
2011-06-15 |
长春华普生物技术有限公司 |
对人b细胞肿瘤有治疗作用的人工合成的单链脱氧核苷酸
|
|
PL2380584T3
(pl)
|
2005-07-01 |
2014-03-31 |
Index Pharmaceuticals Ab |
Sposób do immunostymulacji
|
|
US8148341B2
(en)
|
2005-07-01 |
2012-04-03 |
Index Pharmaceuticals Ab |
Method for modulating responsiveness to steroids
|
|
BRPI0612408A2
(pt)
*
|
2005-07-07 |
2010-11-03 |
Pfizer |
terapia para tratamento de cáncer em combinação com anticorpo anti-ctla-4 e oligodesoxinucleotìdeo sintético contendo o motivo cpg
|
|
US20090306177A1
(en)
*
|
2005-09-16 |
2009-12-10 |
Coley Pharmaceutical Gmbh |
Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification
|
|
CN101310019A
(zh)
*
|
2005-09-16 |
2008-11-19 |
科利制药公司 |
具有磷酸二酯主链的免疫刺激性单链核糖核酸
|
|
RU2311916C2
(ru)
*
|
2005-09-27 |
2007-12-10 |
Галина Михайловна Сафонова |
Средство, обладающее антианемическим, иммуномодулирующим, адаптогенным действием (варианты)
|
|
CA2625969A1
(en)
|
2005-10-28 |
2007-05-03 |
Index Pharmaceuticals Ab |
Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
|
|
CN101594877A
(zh)
*
|
2005-11-02 |
2009-12-02 |
杜克大学 |
同时的化学疗法和免疫疗法
|
|
EP2368572B1
(en)
|
2005-11-04 |
2020-03-04 |
Seqirus UK Limited |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
AU2006310339B2
(en)
|
2005-11-04 |
2013-01-10 |
Novartis Ag |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
US20110180430A1
(en)
|
2005-11-04 |
2011-07-28 |
Novartis Vaccines And Diagnostics Srl |
Adjuvanted influenza vaccines including cytokine-inducing agents
|
|
US20090304742A1
(en)
|
2005-11-04 |
2009-12-10 |
Novartis Vaccines And Diagnostics Srl |
Influenza vaccines with reduced amount of emulsion adjuvant
|
|
CN102864152B
(zh)
*
|
2005-11-07 |
2015-11-18 |
艾德拉药物股份有限公司 |
包含经修饰的免疫刺激性二核苷酸的基于寡核苷酸的化合物之免疫刺激特性
|
|
AU2006318464B2
(en)
|
2005-11-25 |
2011-02-17 |
Zoetis Belgium Sa |
Immunostimulatory oligoribonucleotides
|
|
WO2007068747A1
(en)
|
2005-12-14 |
2007-06-21 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
NZ570106A
(en)
|
2006-01-27 |
2012-04-27 |
Novartis Vaccines & Diagnostic |
Influenza vaccines containing hemagglutinin and matrix proteins
|
|
CA2641026A1
(en)
*
|
2006-02-01 |
2007-08-09 |
The Johns Hopkins University |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
US8168164B2
(en)
|
2006-02-03 |
2012-05-01 |
Purdue Research Foundation |
Targeted conjugates and radiation
|
|
ES2526879T3
(es)
*
|
2006-02-15 |
2015-01-16 |
Adiutide Pharmaceuticals Gmbh |
Composiciones y procedimientos para formulaciones de oligonucleótidos
|
|
CN100418583C
(zh)
*
|
2006-02-21 |
2008-09-17 |
朱鸿飞 |
预防和治疗乳腺炎的药物组合物
|
|
CA2646349A1
(en)
|
2006-03-24 |
2007-10-04 |
Novartis Vaccines And Diagnostics Gmbh & Co Kg |
Storage of influenza vaccines without refrigeration
|
|
US9107863B2
(en)
|
2006-03-27 |
2015-08-18 |
The Buck Institute For Age Reasearch |
Reagents and methods for cancer treatment and prevention
|
|
EP2382988A1
(en)
|
2006-03-31 |
2011-11-02 |
Novartis AG |
Combined mucosal and parenteral immunization against HIV
|
|
CA2651042A1
(en)
|
2006-05-05 |
2007-12-13 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of sglt2
|
|
RU2464030C2
(ru)
*
|
2006-05-26 |
2012-10-20 |
Регадо Байосайенсиз, Инк. |
Введение противосвертывающей системы reg1
|
|
WO2009030978A2
(en)
|
2006-06-09 |
2009-03-12 |
Novartis Ag |
Conformers of bacterial adhesins
|
|
PL2032592T3
(pl)
|
2006-06-12 |
2013-11-29 |
Kuros Biosciences Ag |
Sposoby pakowania oligonukleotydów do cząstek wirusopodobnych z bakteriofagów RNA
|
|
US20100129403A1
(en)
|
2006-06-20 |
2010-05-27 |
Transgene S.A. |
Recombinant viral vaccine
|
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
|
CA3016948A1
(en)
|
2006-09-11 |
2008-03-20 |
Seqirus UK Limited |
Making influenza virus vaccines without using eggs
|
|
MX2009003398A
(es)
|
2006-09-27 |
2009-08-12 |
Coley Pharm Gmbh |
Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada.
|
|
WO2008057529A2
(en)
*
|
2006-11-06 |
2008-05-15 |
Coley Pharmaceutical Group, Inc. |
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
|
|
PT2121011E
(pt)
|
2006-12-06 |
2014-07-31 |
Novartis Ag |
Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
|
|
UA100370C2
(uk)
|
2006-12-11 |
2012-12-25 |
Мериал Лимитед |
Спосіб вакцинації птахів проти salmonella
|
|
AU2007333147B2
(en)
|
2006-12-12 |
2013-12-19 |
Kuros Us Llc |
Oligonucleotides containing high concentrations of guanine monomers
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
NZ582595A
(en)
|
2007-06-27 |
2012-07-27 |
Novartis Ag |
Low-additive influenza vaccines
|
|
TR201000668T1
(tr)
*
|
2007-07-31 |
2010-06-21 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Neoplasti̇k veya enfeksi̇yoz bozukluklara yöneli̇k i̇mmunoprofi̇laksi̇ veya i̇mmünoterapi̇ i̇çi̇n poli̇pepti̇d-nüklei̇k asi̇t konjugati
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
AU2008317261B2
(en)
|
2007-10-26 |
2015-04-09 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of immune responses and autoimmunity
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
WO2009094191A2
(en)
|
2008-01-25 |
2009-07-30 |
Chimerix, Inc. |
Methods of treating viral infections
|
|
EP2268309B1
(en)
|
2008-03-18 |
2015-01-21 |
Novartis AG |
Improvements in preparation of influenza virus vaccine antigens
|
|
BRPI0915605B8
(pt)
|
2008-05-08 |
2021-09-08 |
The Government Of The Us Secretary Of The Dept Of Healt & Human Services |
Vacina de leishmania usando imunógeno salivar de mosca tipo borrachudo
|
|
TWI351288B
(en)
*
|
2008-07-04 |
2011-11-01 |
Univ Nat Pingtung Sci & Tech |
Cpg dna adjuvant in avian vaccines
|
|
KR101881596B1
(ko)
|
2008-12-02 |
2018-07-24 |
웨이브 라이프 사이언시스 재팬 인코포레이티드 |
인 원자 변형된 핵산의 합성 방법
|
|
MX358603B
(es)
|
2008-12-04 |
2018-08-28 |
Curna Inc |
Tratamiento de enfermedades relacionadas con un gen supresor de tumor mediante inhibicion del transcrito antisentido natural para el gen.
|
|
US8552165B2
(en)
*
|
2008-12-09 |
2013-10-08 |
Heather Davis |
Immunostimulatory oligonucleotides
|
|
WO2010067262A1
(en)
|
2008-12-09 |
2010-06-17 |
Pfizer Inc. |
Immunostimulatory oligonucleotides
|
|
WO2010093906A2
(en)
*
|
2009-02-12 |
2010-08-19 |
Curna, Inc. |
Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
|
|
EP3009150B1
(en)
*
|
2009-02-12 |
2019-11-13 |
CuRNA, Inc. |
Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
|
|
JP2012519482A
(ja)
|
2009-03-06 |
2012-08-30 |
ノバルティス アーゲー |
クラミジア抗原
|
|
PL2411521T3
(pl)
|
2009-03-25 |
2015-08-31 |
Univ Texas |
Kompozycje do stymulacji wrodzonej odporności immunologicznej na patogeny u ssaków
|
|
EP2413953B1
(en)
|
2009-04-03 |
2017-11-08 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
|
MX2011010735A
(es)
|
2009-04-14 |
2012-01-25 |
Novartis Ag |
Composiciones para inmunizacion contra staphylococcus aureus.
|
|
DE102010018462A1
(de)
|
2009-04-27 |
2011-04-07 |
Novartis Ag |
Impfstoffe zum Schutz gegen Influenza
|
|
BR112012000828A8
(pt)
|
2009-07-06 |
2017-10-10 |
Ontorii Inc |
Novas pró-drogas de ácido nucleico e métodos de uso das mesmas
|
|
US10988511B2
(en)
|
2009-07-07 |
2021-04-27 |
Glaxosmithkline Biologicals Sa |
Conserved Escherichia bacterial IG-like domain (group 1) protein (ORF405) immunogens
|
|
EP3178490B1
(en)
|
2009-07-15 |
2022-04-20 |
GlaxoSmithKline Biologicals S.A. |
Rsv f protein compositions and methods for making same
|
|
US8871214B2
(en)
|
2009-07-16 |
2014-10-28 |
Novartis Ag |
Detoxified Escherichia coli immunogens
|
|
US20120252869A1
(en)
*
|
2009-07-24 |
2012-10-04 |
Opko Curna, Llc |
Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
|
|
ES2664591T3
(es)
*
|
2009-09-25 |
2018-04-20 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con la filagrina (flg) mediante la modulación de la expresión y actividad del gen FLG
|
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
|
RU2414223C1
(ru)
*
|
2009-11-16 |
2011-03-20 |
Общество с ограниченной ответственностью "Саентифик Фьючер Менеджемент" |
Средство, обладающее иммуностимулирующим и гемостимулирующим действием
|
|
CN108707584A
(zh)
|
2009-11-17 |
2018-10-26 |
Musc研究发展基金会 |
针对人核仁素的人单克隆抗体
|
|
US8592650B2
(en)
|
2009-11-23 |
2013-11-26 |
Bayer Cropscience N.V. |
Elite event EE-GM3 and methods and kits for identifying such event in biological samples
|
|
PH12012501097B1
(en)
|
2009-11-23 |
2019-01-23 |
BASF Agricultural Solutions Seed US LLC |
Herbicide tolerant soybean plants and methods for identifying same
|
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
|
|
PT2534150T
(pt)
|
2010-02-12 |
2017-05-02 |
Chimerix Inc |
Métodos para tratar uma infecção viral
|
|
AU2011248620B2
(en)
|
2010-04-26 |
2015-11-26 |
Chimerix, Inc. |
Methods of treating retroviral infections and related dosage regimes
|
|
RU2431497C1
(ru)
*
|
2010-05-05 |
2011-10-20 |
Илья Александрович Марков |
Комбинированное лекарственное средство, обладающее противогрибковым, противовирусным, противомикробным, противовоспалительным, иммуномодулирующим и бактерицидным действием для наружного или локального применения
|
|
JP6324068B2
(ja)
|
2010-05-26 |
2018-05-23 |
セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． |
合成ナノキャリア混合ワクチン
|
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
|
WO2011159958A2
(en)
|
2010-06-16 |
2011-12-22 |
Dynavax Technologies Corporation |
Methods of treatment using tlr7 and/or tlr9 inhibitors
|
|
JP6023705B2
(ja)
*
|
2010-06-23 |
2016-11-09 |
カッパーアールエヌエー，インコーポレイテッド |
ナトリウムチャネル、電位依存性、αサブユニット（ＳＣＮＡ）に対する天然アンチセンス転写物の阻害によるＳＣＮＡ関連疾患の治療
|
|
ES2557382T3
(es)
*
|
2010-07-06 |
2016-01-25 |
Glaxosmithkline Biologicals Sa |
Liposomas con lípidos que tienen un valor de pKa ventajoso para el suministro de ARN
|
|
WO2012039448A1
(ja)
|
2010-09-24 |
2012-03-29 |
株式会社キラルジェン |
不斉補助基
|
|
US9994443B2
(en)
|
2010-11-05 |
2018-06-12 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
|
DK2667892T3
(da)
|
2011-01-26 |
2019-05-13 |
Glaxosmithkline Biologicals Sa |
RSV-vaccineringsprogram
|
|
WO2012142480A1
(en)
*
|
2011-04-14 |
2012-10-18 |
Beth Israel Deaconess Medical Center, Inc. |
Chimeric rna oligonucleotides and uses thereof
|
|
SI3275892T1
(sl)
|
2011-05-13 |
2020-06-30 |
Glaxosmithkline Biologicals S.A. |
Prefuzijski RSV F antigeni
|
|
CN103748111B
(zh)
|
2011-05-20 |
2018-04-27 |
奥尔德生物控股有限责任公司 |
抗cgrp组合物及其用途
|
|
EP2709662B1
(en)
|
2011-05-20 |
2019-07-31 |
AlderBio Holdings LLC |
Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
|
|
KR101965461B1
(ko)
*
|
2011-05-20 |
2019-04-04 |
앨더바이오 홀딩스 엘엘씨 |
필요한 대상체, 특히 편두통 환자의 광선공포증 또는 광선 혐오증을 예방 또는 억제하기 위한 항-cgrp 항체 및 항체 단편의 용도
|
|
CN103796639B
(zh)
*
|
2011-07-06 |
2017-05-31 |
诺华股份有限公司 |
阳离子水包油乳液
|
|
WO2013009701A2
(en)
|
2011-07-08 |
2013-01-17 |
The University Of North Carolina At Chapel Hill |
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
|
|
WO2013009564A1
(en)
|
2011-07-08 |
2013-01-17 |
Novartis Ag |
Tyrosine ligation process
|
|
BR112014001244A2
(pt)
|
2011-07-19 |
2017-02-21 |
Wave Life Sciences Pte Ltd |
métodos para a síntese de ácidos nucléicos funcionalizados
|
|
AU2012284558B2
(en)
|
2011-07-20 |
2017-06-29 |
Centre National De La Recherche Scientifique |
Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
|
|
CN109172819A
(zh)
|
2011-07-29 |
2019-01-11 |
西莱克塔生物科技公司 |
产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
|
|
CN104080479B
(zh)
|
2011-11-07 |
2019-11-05 |
葛兰素史密丝克莱恩生物有限公司 |
包括spr0096和spr2021抗原的运载体分子
|
|
CN104520439A
(zh)
*
|
2012-02-28 |
2015-04-15 |
国立大学法人东京农工大学 |
Tdp-43细胞内存在量关联疾患的认定方法
|
|
EP2827897B1
(en)
|
2012-03-20 |
2018-10-31 |
Merial, Inc. |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
|
|
JP2014012650A
(ja)
*
|
2012-07-05 |
2014-01-23 |
Nihon Univ |
上皮バリア機能の増強方法及び増強剤
|
|
RU2015104762A
(ru)
|
2012-07-13 |
2018-08-31 |
Уэйв Лайф Сайенсес Лтд. |
Хиральный контроль
|
|
BR112015000784A8
(pt)
|
2012-07-13 |
2018-04-03 |
Wave Life Sciences Japan |
Grupo auxiliar assimétrico
|
|
BR112015000723A2
(pt)
*
|
2012-07-13 |
2017-06-27 |
Shin Nippon Biomedical Laboratories Ltd |
adjuvante de ácido nucléico quiral
|
|
AU2013308627B2
(en)
|
2012-08-30 |
2016-10-27 |
Boehringer Ingelheim Animal Health USA Inc. |
Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure
|
|
CN105307684A
(zh)
|
2012-10-02 |
2016-02-03 |
葛兰素史密丝克莱恩生物有限公司 |
非直链糖缀合物
|
|
SG11201504258RA
(en)
|
2012-11-30 |
2015-07-30 |
Glaxosmithkline Biolog Sa |
Pseudomonas antigens and antigen combinations
|
|
CN105026427B
(zh)
|
2013-02-20 |
2019-12-24 |
依奈特制药公司 |
特异性结合至kir3dl2的化合物用于治疗外周t细胞淋巴瘤
|
|
US9427647B2
(en)
*
|
2013-04-26 |
2016-08-30 |
Russell I. Moy |
Climbing hold assembly having load dissipative effect
|
|
JP6865582B2
(ja)
*
|
2013-05-29 |
2021-04-28 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Ｋｉｒ３ｄｌ２は皮膚及び非皮膚末梢ｔ細胞リンパ腫のサブセットをそれぞれ予防及び治療するために有用なバイオマーカー及び治療標的である
|
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
|
US20170114122A1
(en)
|
2015-10-23 |
2017-04-27 |
Alderbio Holdings Llc |
Regulation of glucose metabolism using anti-cgrp antibodies
|
|
CN105579582A
(zh)
|
2013-07-25 |
2016-05-11 |
埃克西奎雷股份有限公司 |
用于预防和治疗用途的作为免疫刺激剂的基于球形核酸的构建体
|
|
EP2870974A1
(en)
|
2013-11-08 |
2015-05-13 |
Novartis AG |
Salmonella conjugate vaccines
|
|
WO2015108046A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
|
WO2015108048A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
|
WO2015108047A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
|
WO2015107425A2
(en)
|
2014-01-16 |
2015-07-23 |
Wave Life Sciences Pte. Ltd. |
Chiral design
|
|
WO2015187966A1
(en)
|
2014-06-04 |
2015-12-10 |
Aurasense Therapeutics, Llc |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
CA2968531A1
(en)
|
2014-11-21 |
2016-05-26 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
|
WO2016183486A1
(en)
|
2015-05-13 |
2016-11-17 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
BR112017028011A2
(en)
|
2015-06-26 |
2018-08-28 |
Seqirus UK Limited |
antigenically matched influenza vaccines
|
|
EP3468605A4
(en)
|
2016-06-08 |
2020-01-08 |
President and Fellows of Harvard College |
MANIPULATED VIRAL VECTOR TO REDUCE INDUCTION OF IGNITION AND IMMUNE REACTIONS
|
|
AU2017301528A1
(en)
*
|
2016-07-26 |
2019-02-14 |
Elanco Animal Health Gmbh |
Increased fertility in bovine species
|
|
US11364304B2
(en)
|
2016-08-25 |
2022-06-21 |
Northwestern University |
Crosslinked micellar spherical nucleic acids
|
|
US11696954B2
(en)
|
2017-04-28 |
2023-07-11 |
Exicure Operating Company |
Synthesis of spherical nucleic acids using lipophilic moieties
|
|
US11433131B2
(en)
|
2017-05-11 |
2022-09-06 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (SNAs)
|
|
WO2019028250A1
(en)
|
2017-08-02 |
2019-02-07 |
The University Of Chicago |
NOMOGENEOUS ORGANOMETALLIC ORGANOMETRIC ORGANOMETRIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF
|
|
WO2019094548A1
(en)
|
2017-11-08 |
2019-05-16 |
President And Fellows Of Harvard College |
Compositions and methods for inhibiting viral vector-induced inflammatory responses
|
|
US11932857B2
(en)
*
|
2017-12-15 |
2024-03-19 |
Elanco Animal Health Gmbh |
Immunostimulatory oligonucleotides
|
|
BR112020018192A2
(pt)
|
2019-01-08 |
2021-08-24 |
H. Lundbeck A/S |
Tratamento agudo e tratamento rápido de dor de cabeça com o uso de anticorpos anti-cgrp
|
|
AU2020403296B2
(en)
*
|
2019-12-13 |
2025-03-06 |
Grand Theravac Life Science (Nanjing) Co., Ltd. |
Immunostimulatory composition and use thereof
|
|
US20230241196A1
(en)
|
2020-01-27 |
2023-08-03 |
Oregon State University |
Gonorrhea subunit vaccine
|
|
AU2020202454A1
(en)
|
2020-04-06 |
2021-10-21 |
H. Lundbeck A/S |
Treatment of most bothersome symptom (MBS) associated with migraine using anti-CGRP antibodies
|
|
CN114181888B
(zh)
*
|
2021-11-24 |
2023-12-08 |
汕头大学 |
一种浅色黄姑鱼鱼鳔细胞系的建立方法及应用
|
|
CN115252603A
(zh)
*
|
2022-07-08 |
2022-11-01 |
深圳市第二人民医院(深圳市转化医学研究院) |
indisulam在制备治疗膀胱癌的药物中的应用
|